You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.
This week, NYSE-listed company Scotts Miracle-Gro reported $303 million quarterly revenue from its cannabis-focused division, Hawthorne Gardening, with profits of $41 million. There are several other companies listed on major exchanges that are doing substantial business with state-legal but federally illegal American cannabis operators, and many others, like banks and power companies, that work with them as well. Yet, as most of our readers are aware, the major exchanges don’t permit American cannabis companies to list due to federal illegality. We think this could change.
Just as there is no law that specifically precludes banks from working with cannabis operators, the major exchanges aren’t restricted from listing them. Instead, it’s a business decision that they have made to avoid risk. Absent any safe harbor, like a new law or at least a memorandum from the federal government, the exchanges are not likely to take a more aggressive approach, as they have too much to lose otherwise. With the Senate potentially changing control, we think it’s time to imagine what rationalization of federal policy might look like, including topics that are often discussed, such as banking and research reforms, but also capital market access, all of which could happen without what would likely be a long and complex task of federal legalization.
If American cannabis companies were able to list on the major exchanges, capital access would expand significantly overnight. For example, retail broker Robinhood, which has grown in popularity, does not offer trading in OTC stocks, which is where all American cannabis operators are forced to list. Additionally, large institutions typically have little interest in buying stocks on the CSE or the OTC. We are also aware that some brokerages currently can make it difficult for individuals to trade cannabis stocks, with higher commissions or order placement only by phone.
One of the catalysts for the bull market in Canadian LP stocks was listing in the United States, which began in early 2018 when Cronos listed on the NASDAQ followed by Canopy Growth listing on the NYSE. Today, most of the largest LPs trade on major American exchanges, typically experiencing substantially higher trading volumes there than in Canada. Two LPs, Sundial and Tilray, don’t trade at all in Canada. The ATM offerings that the LPs have been conducting tend to be executed in the United States as well.
The SAFE Banking Act, which never advanced, didn’t address this topic, but we are hopeful that the next round of legislation will include language about trading exchanges as well as credit card processing. Just as we have argued that many state and local jurisdictions are becoming friendlier to the legal cannabis industry in light of the current economic crisis, we think the federal government, with a unified Congress, could pave the way for rational reforms.
After humble beginnings that started in 2011 when the Stanley brothers first developed what would be the company’s proprietary genetics, Charlotte’s Web has become the most recognized American CBD brand derived from industrial hemp. The company’s strong brand and its e-commerce prowess have enabled it to persevere in a highly competitive market.
Charlotte’s Web has upgraded its management team and has proven its ability to access institutional capital with the secured credit line from J.P Morgan this year. Today, the company’s CBD products, which include oils, gummies, capsules, topicals and canine products, are sold in over 21,000 retail stores. As of Q1, almost 2/3 of its business is now through e-commerce. With the completed acquisition of Abacus Health, the company has expanded to focus on skin conditions and pain relief and has dramatically expanded its presence with food, drug stores and mass retailers
Get up to speed by visiting the Charlotte’s Web Holdings Dashboard that we maintain on their behalf as a client of New Cannabis Ventures. Click the blue Follow Company button in order to stay up to date with their progress.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:
- Exclusive: American Cannabis Companies Expected to Report Strong Revenue Growth
- Aphria Q4 Cannabis Revenue Increases 81% to $53.1 Million
- Exclusive: Family-Owned Quality Roots Finds Success in Michigan Cannabis Market During Pandemic
- Hawthorne Gardening Q3 Sales Grow 72% to $303 Million
- Guest Post: How to Assess Cannabis Operator Intangible Assets
- Liberty Health Sciences Q1 Revenue Increases 234% to C$18.4 Million
- Exclusive: SLANG Doubles Down on Emerging Cannabis Markets Under New CEO
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.
View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5M per quarter.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Alan & Joel